Roman DBDR Tech Sponsor LLC - 27 Dec 2021 Form 4 Insider Report for CompoSecure, Inc. (CMPO)

Role
10%+ Owner
Signature
/s/ Dr. Donald G. Basile, as Authorized Signatory
Issuer symbol
CMPO
Transactions as of
27 Dec 2021
Net transactions value
$0
Form type
4
Filing time
29 Dec 2021, 20:31:54 UTC
Next filing
18 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMPO Class A Common Stock Options Exercise $0 +5,789,000 $0.000000 5,789,000 27 Dec 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPO Class B Common Stock Options Exercise -5,789,000 -100% 0 27 Dec 2021 Class A Common Stock 5,789,000 Direct F1, F2
transaction CMPO Warrants Award +10,837,400 10,837,400 27 Dec 2021 Class A Common Stock 10,837,400 $11.50 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 27, 2021, Roman DBDR Tech Acquisition Corp. closed the previously announced business combination with CompoSecure Holdings, L.L.C. (the "Business Combination") pursuant to which CompoSecure, Inc. became a publicly-traded company (the "Company"). As a result of the Business Combination, each outstanding share of Class B Common Stock converted automatically on a one-for-one basis into shares of Class A Common Stock.
F2 Dr. Donald G. Basile, Chairman and Co-Chief Executive Officer of the registrant and Dixon Doll, Jr., the registrant's Co-Chief Executive Officer, are the managing members of the reporting person and have voting and investment discretion with respect to the securities held by the reporting person. As such, Messrs. Basile and Doll may be deemed to share beneficial ownership of the shares of Class A common stock held directly by the reporting person. Each of Messrs. Basile and Doll disclaim any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.
F3 Pursuant to the terms of the Company's warrants to purchase shares of Class A Common Stock, upon completion of the Business Combination, the warrants became exercisable beginning 30 days thereafter.
F4 Dr. Donald G. Basile, Chairman and Co-Chief Executive Officer of the registrant and Dixon Doll, Jr., the registrant's Co-Chief Executive Officer, are the managing members of the reporting person and have voting and investment discretion with respect to the securities held by the reporting person. As such, Messrs. Basile and Doll may be deemed to share beneficial ownership of the warrants held directly by the reporting person. Each of Messrs. Basile and Doll disclaim any beneficial ownership of the warrants other than to the extent of any pecuniary interest they may have therein, directly or indirectly.